title: Ochoa syndrome: a spectrum of urofacial syndrome.
abstract: The urofacial syndrome, also known as Ochoa syndrome, is a rare autosomal recessive condition that occurs in both genders and characterized by uropathy and facial abnormalities. Early diagnosis is crucial for the management and prognosis of urinary problems due to a dysfunctional bladder. We report 11 patients with urofacial syndrome in five families from Turkey with a median follow up of 32 months (range, 2-44 months).
authors: Division of Pediatric Urology, School of Medicine, Ankara University, Ankara, Turkey. ozgucan@yahoo.com
authors: Ozgu
authors: O
authors: Aydogdu
authors: Berk
authors: B
authors: Burgu
authors: Fuat
authors: F
authors: Demirel
authors: Tarkan
authors: T
authors: Soygur
authors: Zeynep Birsin
authors: ZB
authors: Ozcakar
authors: Fatos
authors: F
authors: Yalcinkaya
authors: Serdar
authors: S
authors: Tekgul
mesh_terms: D000015:Abnormalities, Multiple; D019072:Antibiotic Prophylaxis / Q000379:methods; D002404:Catheterization / Q000379:methods; D002648:Child; D018680:Cholinergic Antagonists / Q000627:therapeutic use; D003131:Combined Modality Therapy; D005145:Face / Q000002:abnormalities*; D005149:Facial Expression; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D013577:Syndrome; D001750:Urinary Bladder, Neurogenic / Q000150:complications* / Q000628:therapy; D014549:Urinary Incontinence / Q000150:complications* / Q000628:therapy; D014552:Urinary Tract Infections / Q000150:complications* / Q000628:therapy; D014718:Vesico-Ureteral Reflux / Q000150:complications* / Q000628:therapy
chemical_list: D018680:Cholinergic Antagonists